Oskar Vilhelmsson Timmermand

knuten till universitetet
Fler filtreringsmöjligheter
  1. 2019
  2. Preclinical efficacy of hK2 targeted [177Lu]hu11B6 for prostate cancer theranostics

    Oskar Vilhelmsson Timmermand, Elgqvist, J., Beattie, K. A., Anders Örbom, Erik Larsson, Sophie E Eriksson, Thorek, D. L. J., Beattie, B. J., Thuy A Tran, David Ulmert & Sven-Erik Strand, 2019, I : Theranostics. 9, 8, s. 2129-2142 14 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. 2018
  4. Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer

    McDevitt, M. R., Thorek, D. L. J., Hashimoto, T., Gondo, T., Veach, D. R., Sharma, S. K., Kalidindi, T. M., Abou, D. S., Watson, P. A., Beattie, B. J., Oskar Vilhemsson Timmermand, Sven Erik Strand, Lewis, J. S., Scardino, P. T., Scher, H. I., Hans Lilja, Larson, S. M. & David Ulmert, 2018 dec 1, I : Nature Communications. 9, 1, 1629.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. 2016
  6. High resolution digital autoradiographic and dosimetric analysis of heterogeneous radioactivity distribution in xenografted prostate tumors

    Oskar Vilhelmsson Timmermand, Nilsson, J., Sven Erik Strand & Elgqvist, J., 2016 dec 1, I : Medical Physics. 43, 12, s. 6632-6643 12 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. Radioimmunotherapy of prostate cancer targeting human kallikrein-related peptidase 2

    O. Vilhelmsson Timmermand, Erik Larsson, Ulmert, D., T. A. Tran & S. E. Strand, 2016 dec 1, I : EJNMMI Research. 6, 1, 27.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. 2015
  9. Diffuse reflectance spectroscopy of liver tissue

    Nina Reistad, Jan Nilsson, Oskar Vilhelmsson Timmermand, Sturesson, C. & Stefan Andersson-Engels, 2015, [Host publication title missing]. SPIE, Vol. 9531. s. 95314E 10 s.

    Forskningsoutput: Kapitel i bok/rapport/Conference proceedingKonferenspaper i proceeding

  10. 2014
  11. Preclinical imaging of kallikrein-related peptidase 2 (hK2) in prostate cancer with a In-111-radiolabelled monoclonal antibody, 11B6

    Oskar Vilhelmsson Timmermand, Ulmert, D., Evans-Axelsson, S., Pettersson, K., Bjartell, A., Lilja, H., Sven-Erik Strand & Thuy Tran, 2014, I : EJNMMI Research. 4, 51.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  12. Radioimmunoimaging and Radioimmunotherapy of Prostate Cancer Preclinical evaluation of kallikrein related peptidase 2 targeting

    Oskar Vilhelmsson Timmermand, 2014, Department of Medical Radiation Physics, Clinical Sciences, Lund, Lund University. 118 s.

    Forskningsoutput: AvhandlingDoktorsavhandling (monografi)